February 16, 2015
Otsuka Holdings President Tatsuo Higuchi Otsuka Holdings will move to realign personnel to optimize costs in the face of a US patent expiry of its bread-and-butter antipsychotic Abilify (aripiprazole) in April, which would deal a crushing blow to the company’s...read more